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Perfringolysin O (PFO) is a toxic protein that forms β-barrel transmembrane pores upon binding to cholesterol-containing membranes. The formation of lytic pores requires conformational changes in PFO that lead to the conversion of water-soluble monomers into membrane-bound oligomers. Although the general outline of stepwise pore formation has been established, the underlying mechanistic details await clarification. To extend our understanding of the molecular mechanisms that control the pore formation, we compared the hydrogen-deuterium exchange patterns of PFO with its derivatives bearing mutations in the D3 domain. In the case of two of these mutations F318A, Y181A, known from previous work to lead to a decreased lytic activity, global destabilization of all protein domains was observed in their water-soluble forms. This was accompanied by local changes in D3 -sheet, including unexpected stabilization of functionally important 1 strand in Y181A. In case of the double mutation (F318A/Y181A) that completely abolished the lytic activity, several local changes were retained, but the global destabilization effects of single mutations were reverted and hydrogen-deuterium exchange (HDX) pattern returned to PFO level. Strong structural perturbations were not observed in case of remaining variants in which other residues of the hydrophobic core of D3 domain were substituted by alanine. Our results indicate the existence in PFO of a well-tuned H-bonding network that maintains the stability of the D3 β-strands at appropriate level at each transformation step. F318 and Y181 moieties participate in this network and their role extends beyond their direct intermolecular interaction during oligomerization that was identified previously. 




Perfringolysin O (PFO) is a toxic protein that is produced and secreted by the anaerobic bacterium Clostridium perfringens. PFO is a representative member of a large group of β-barrel pore-forming toxins called cholesterol-dependent cytolysins (CDCs). The CDCs include numerous toxins that are produced by Gram-positive bacterial species that are pathogenic in humans and animals, including streptolysin O (S. pyogenes), pneumolysin (S. pneumoniae), and listeriolysin O (L. monocytogenes) [1–7]. PFO was the first CDC member for which the crystallographic structure of the soluble monomeric form was solved [6]. Crystallography revealed that PFO has four distinct domains that are conserved in all CDCs and that are dominated by β-strands [6–11] (Fig. 1A). For this reason, PFO is commonly considered a model CDC in studies that investigate the CDC pore-forming mechanism. The overall mechanism involved in the pore formation of several CDCs is relatively well characterized and requires several steps: recognition and binding to cholesterol; oligomerization of the soluble monomers on the membrane surface (prepore creation); and insertion of defined PFO regions into the lipid bilayer to form a large amphipathic transmembrane β-barrel pore with a diameter of 250–300 Å [12–15]. 
PFO is secreted by bacteria as a single, monomeric molecule that initially binds to cholesterol-containing membrane via a C-terminal lipid binding motif located in the D4 domain [16–19]. This interaction leads to allosteric signal transmission from the D4 domain to the other domains that induces structural changes in the PFO monomers (20-22). This structural rearrangement initiates weak and reversible monomer-monomer interactions that lead to the formation of SDS-sensitive arc- or ring-shaped oligomers (early prepores) and finally to pore formation [14,17,23-25]. The initial interaction between neighboring monomers triggers a cascade of structural changes in the D2 and D3 domains that increase the number of intermolecular interactions and thereby maintain monomers in the correct position to form ring-shaped SDS-resistant oligomers, termed late prepores [24-28]. Appropriate rigidity of D1 domain fine-tunes the stiffness of a network of its β-strands that intercalate with other domains, thus orchestrates the triggering of the necessary structural changes [29].
The transition from early to late prepores is promoted by the formation of hydrogen bonds between the β-strands of the D3 domain of neighboring monomers and specifically by the interaction of the β1 strand of one monomer with the β4 strand of a second monomer [12,24,30]. This contact between strands is enabled by the rotation of the β5 strand away from the β4 strand in the D3 domain; this rotation exposes β4 to the polar environment (Fig. 1B) [30]. The π-stacking interaction between Y181 in β1 of one monomer and F318 in β4 of a different monomer was shown to be essential for forcing and stabilizing their proper orientation, thereby defining the pore geometry and the size of the growing oligomers [30]. As a result of stable D3-mediated interactions between monomers, the signal from the tip of the D4 domain is transmitted to the D1 domain, substantially stabilizing it, and to the D2 domain, which undergoes conformational changes that induce the vertical collapse of PFO along its longitudinal axis. This collapse destabilizes the D2-D3 contact surface and brings TMH-1 and TMH-2 of the D3 domain in close proximity to the membrane [31,32]. The subsequent prepore-pore transition is controlled by an intermolecular electrostatic interaction between E183 and K336 that stabilizes the D3–D1,2 interface and provides the necessary free energy to overcome the prepore-pore transition state barrier [24]. Finally, two helical bundles (TMH1 and TMH2) that are composed of three α-helices undergo changes in their secondary structure that lead to the formation of amphipathic β-hairpins that insert into the membrane and create a transmembrane β-barrel pore [12,30,32,33]. 
The series of steps that leads to the creation of a pore has been established by meticulous mutational analysis and by the interpolation of structural events between the known structures of the starting monomeric state and the final pore [32,33]. However, direct analysis has not revealed the atomic-level structures that are present during the intermediate steps that would explain the process in greater detail. A deeper understanding of the complex structural transition thus requires the use of new, non-standard structure analysis approaches that allow more precise characterization of the role of different residues in this dynamic process.
Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) gives unique insights into the structural dynamics of proteins, both in solution and upon interaction with the lipid membrane, revealing the structural changes that accompany the transitions of protein forms with high reproducibility and precision [29,34,35]. Previously we used this method to study PFO and its derivatives, PFOW165T and PFOR468A, to demonstrate the role of the D1 domain in PFO pore formation as well as the toxin activity mode switch due to modification of D4 domain [29,34]. In this study we used HDX-MS method in order to analyze the impact of point mutations introduced into the β1 or/and β4 strands (F318A, Y181A, and F318A/Y181) on the molecular mechanisms that are responsible for the structural transition of PFO from a prepore state to a pore complex. Previous studies have shown that introduction of the single point mutations Y181A or F318A arrests PFO oligomers in the prepore state affecting the lytic activity of these proteins [26,30,32,36].
	Our results demonstrate that in general the single mutations Y181A and F318A lead to similar changes in the structural dynamics of the solution form of PFO. Both mutations strongly destabilized all domains of the protein. Unexpectedly, we found that the pattern of deuteration in the PFO double mutant, PFOF318A/Y181A, was much closer to the pattern of PFO than to the patterns of the single-site mutants. In the majority of PFO regions, the double mutation compensated for the destabilization caused by the single-site mutations without restoring the lytic activity. We also found that the Y181A mutation lead to stabilization of crucial structural elements, suggesting that natively decreased stability in these elements in PFO serves as a finely-tuned molecular mechanism that allows control over the structural transitions. 
	These results indicate that the structural rearrangements that determine the lytic activity of PFO may also depend on allosteric dysregulation of a fine-tuned interaction network that encompasses the entire protein and acts in addition to local side chain-side chain interactions of residues under study. As a result, the findings underscore the role of structural dynamics in PFO and provide new information about the detailed molecular mechanisms that drive conformational changes in PFO during oligomerization and are essential for the lytic activity of this protein. 

2.	Materials and methods 
2.1.	 Expression and purification of PFO and its derivatives 
The synthetic PFO gene was prepared with single point mutation C459A [37] and cloned into the pGEX-4T3 expression vector as described previously [29]. This cysteine-less toxin is referred to simply as PFO. To obtain a tag-less PFO derivative, the sequence encoding the ENLYFQG motif, which is recognized by the Tobacco Etch Virus (TEV) protease, was added between GST and the PFO sequence [29,34,38]. The PFO mutant derivatives bearing mutations: F318A, Y181A, F318Y, Y181F, L224A, L281A, I298A F338A, F318A/Y181A were prepared using site-directed mutagenesis and then overexpressed in E. coli strain BL21(DE3) and purified as described previously [29,34,38]. Briefly, the bacterial culture was induced with IPTG (18 °C for 20 h), lysed in the presence of 0.35 mg/ml lysozyme and 1% Triton X-100 (10 min, 4 °C), and sonicated on ice (15 min, 0.3 cycle, amplitude 33%). The suspension was clarified by centrifugation (18 000 × g, 30 min, 4 °C) and loaded onto a Glutathione Sepharose 4B column (GE Healthcare). After washing with phosphate buffer supplemented with 100 mM NaCl and 1 mM DTT, the GST-tagged proteins that were bound to the column were treated with 50 μg of TEV protease for 3 h at 30 °C in 50 mM Tris pH 8.0 buffer supplemented with 1 mM DTT. To remove the TEV protease, proteins released from the column were loaded onto a HisLink Protein Purification Resin column (Promega). Tag-less PFO proteins that were recovered from the column were pooled and loaded onto a PD-10 desalting column for buffer exchange into 100 mM NaCl, 1 mM DTT, and 50 mM Tris, pH 7.4. Finally, the collected samples were supplemented with 20% sucrose, frozen in liquid nitrogen, and stored at -80 °C.

2.2. Surface plasmon resonance 
The interaction of proteins with large unilamellar vesicles (LUVs) was examined using a BIAcore 3000 instrument (BIAcore, GE Healthcare) equipped with an L1 chip. LUVs composed of DOPC/cholesterol or DOPC/SM (1:1 molar ratio) were prepared as described below, resulting in a 2-mM final lipid concentration [29,38]. The liposomes were deposited onto the surface of an L1 chip using an amount that corresponded to 7000 resonance units (RU). Measurements were conducted using 1 μM of protein at a flow rate of 5 μl/min for 300 s. Dissociation of the deposited protein was followed for another 300 s. 

2.3.	 Preparation of liposomes
For surface plasmon resonance (SPR) measurements, liposomes were prepared as described previously with a final lipid concentration of 2 mM [29,39]. Briefly, mixtures of DOPC/cholesterol or DOPC/SM at a molar ratio of 1:1 were dissolved in organic solvent solution (chloroform:methanol; 1:1 v:v) and dried under a gentle stream of nitrogen on a rotavapor for 3 h. The lipid films were resuspended in buffer A (150 mM NaCl, 30 mM Tris, pH 7.5), vortexed, and subjected to six freeze-thaw cycles. The resulting multilamellar vesicles were extruded through polycarbonate filters with 100-nm pores to create LUVs. 
Small unilamellar vesicles (SUVs) were prepared by suspending the lipid film, which was composed of DOPC/cholesterol in a 1:1 molar ratio, in buffer containing 30 mM Tris and 150 mM NaCl, pH 7.5, subjecting the suspension to six freeze-thaw cycles, and sonicating it at 4 °C (30 min, 0.3 cycle, amplitude 33%). The vesicles were pelleted (10 000 × g, 10 min, 4 °C), resuspended in buffer containing 30 mM Tris and 150 mM NaCl, pH 7.5, and used for HDX-MS experiments or the oligomerization assay.
2.4.	 Oligomerization assay
SUVs (2 mM total lipid concentration; DOPC/cholesterol in a 1:1 molar ratio) were incubated with 1 µM of PFO and its mutant derivatives for 45 min at 25 °C and 37 °C, centrifuged, and resuspended in 20 μl of SDS loading buffer (40% glycerol (v/v), 25% SDS (w/v), and 0.1% bromophenol blue (w/v)). The samples were then analyzed using denaturing SDS-agarose gel electrophoresis (SDS-AGE) as described previously [14]. Briefly, samples were electrophoresed on a 1.5% (w/v) agarose gel for 1.5 h at 90 volts in SDS gel reservoir buffer (192 mM glycine, 25 mM Tris in 0.1% (w/v) SDS) and stained with colloidal Coomassie Blue G250 (PageBlue Protein Staining Solution, Thermo Scientific). 
2.5.	Measurement of lytic activity 
The hemolytic activity of the PFO mutant derivatives was measured as described previously [40]. Briefly, protein dilution series samples were incubated with 7 × 107 sheep red blood cells (RBCs) at 25 °C and 37 °C for 45 min. After centrifugation (200 × g, 5 min, 4 °C), the level of hemoglobin released from RBC was estimated by absorbance measurements at 405 nm using a Spectroquant® Pharo 300 Spectrophotometer (Merck, Darmstadt, Germany) and expressed as a percentage of hemolytic activity. The maximum activity (positive control) was obtained by osmotic lysis of RBCs with water and was considered to be 100% hemolysis. For the negative control, RBCs were resuspended in TBS buffer in the absence of proteins.
2.6.	 Hydrogen-deuterium exchange measurements
HDX-MS experiments were performed as described previously [29,34]. In brief, samples of lipid-bound proteins were prepared by incubating 1 µM PFO or its mutant derivatives with 2 mM liposomes composed of DOPC:cholesterol in a 1:1 molar ratio for 45 min at 25 °C or 37 °C. The samples were centrifuged to remove unbound proteins, and the pellets were suspended in 30 mM Tris, 150 mM NaCl, pH 7.5 buffer. The samples (5 µl) were then diluted into 45 µl of D2O-based reaction buffer (30 mM Tris, 150 mM NaCl, pH 7.5) and incubated for 10 s, 5 min, 20 min, 60 min, or 24 h. To quench the hydrogen-deuterium exchange reaction, the mixture was added to 10 µl of pre-chilled D2O-based stopping buffer (2 M glycine, 150 mM NaCl, pH 2.4), and then supplemented with Triton X-100 to a final concentration 0.2% and vortexed for 2 min at 0 °C to dissolve the liposomes. Finally, the samples were clarified by brief filtration on a spin column (Vivacon 500, Sartorius) to separate the proteins from the lipids of disrupted liposomes and injected onto an immobilized pepsin column (Poroszyme; ABI). Subsequent to online pepsin digestion, the peptides were separated with the nanoACQUITY ultra-performance liquid chromatography (UPLC) system before mass measurements on the SYNAPT G2 HDMS mass spectrometer (Waters, Milford, MA). The HDX-MS data were processed and analyzed using the DynamX 2.0 hydrogen deuterium data analysis program (Waters, Milford, MA). The analysis was based on a list of peptic peptides obtained for a non-deuterated sample using ProteinLynx Global Server software (Waters, Milford, MA), as described previously [29]. The optimized conditions gave over 90 % coverage of sequence of the PFO and all PFO mutant, with 39 common peptic peptides identified for PFO, PFOF318A, PFOY181A, and PFOF318A/Y181A  (Supplementary Fig. 1).
	The HDX-MS measurements for PFOF318A, PFOY181A, and PFOF318A/Y181A were compared with those of PFO in aqueous buffer and upon binding to liposomes, while in the case of mutants: F318Y, Y181F, L224A, L281A, I298A F338A only in aqueous buffer. All measurements were repeated in triplicates. Controls were also performed for each measurement, including a back-exchange control and a carry-over effect control, as described previously [29]. Inconclusive and overlapping isotopic envelopes were manually verified and, when necessary, excluded from the final dataset.
3.	Results
3.1. The F318A and Y181A mutations decrease the lytic activity of PFO but do not affect the cholesterol binding ability of PFO
	The initial binding of PFO to cholesterol-containing membranes is mediated by the D4 domain [17,18,20,41,42]. Previous studies found that mutations in the D4 domain abolished both PFO oligomerization and lytic activity [21]. However, modifications within TMH1 that were located in the D3 domain altered the interaction of the D4 domain with the membrane, showing that these two distant and spatially separated domains of PFO are coupled both structurally and functionally [20,21,36,42]. Therefore, PFO binding properties need to be verified regardless of the location of the mutation site. Binding of the PFO mutant derivatives: PFOF318A, PFOY181A, PFOF318A/Y181A to cholesterol-containing liposomes was measured by SPR. These studies were performed using LUVs composed of DOPC/cholesterol in a molar ratio of 1:1 and a cholesterol/protein ratio of 1000:1. As shown in Fig. 2A, the binding properties of all the PFO mutants to liposomes that contained 50 mol% cholesterol were comparable with PFO, reaching a plateau value of ~4500 RU after a dissociation time of 300 s. These observations are in agreement with previous results which showed marginal changes in binding properties of PFO bearing mutations in aromatic residues in the D3 domain if the cholesterol concentration in liposomes exceeded ∼40 mol%. [19,36,43,44]. Binding of the PFO mutant derivatives to DOPC/SM liposomes allowed us to estimate the nonspecific binding of mutants to cholesterol-depleted liposomes. Analysis of the SPR sensorgrams showed that the nonspecific binding of the PFO mutants was comparable to that of PFO and was very weak and almost completely reversible (Fig. 2B). 
	Binding of PFO to cholesterol-containing membranes initiates the toxin oligomerization process that precedes the formation of transmembrane lytic pores. SDS-AGE analysis revealed that mutations within PFO β1 strand (Y181A) and β4 strand (F318A) of the D3 domain disrupted oligomer formation (Fig. 3A). This was particularly evident when liposomes composed of DOPC/cholesterol were incubated with the proteins at 25 °C. Under these conditions, the formation of SDS-resistant oligomers was completely abolished for the double mutant PFOF318A/Y181A , significantly impaired for PFOY181A, and inhibited to lower extent for PFOF318A. Raising the incubation temperature to 37 °C induced the oligomerization state of PFOF318A to one that was comparable to that of the PFO, improved oligomerization of PFOY181A, but did not affect that of PFOF318A/Y181A (Fig. 3A). 
	Transmembrane pores formed by PFO induce RBCs hemolysis. To determine the impact of the F318A and Y181A mutations on PFO lytic activity, hemoglobin release from sheep RBCs was measured using a hemolysis assay. The single point mutations Y181 and F318 markedly inhibited hemolytic activity for protein concentrations up to 50 nM, both at 25 °C and at 37 °C (Fig. 3B). At protein concentrations greater than 50 nM, the hemolytic activity of PFOF318A and PFOY181A slightly increased and was more pronounced at 37 °C than 25 °C. The hemolytic activity of PFOF318A was higher than PFOY181A, which corresponded to more efficient oligomerization of PFOF318A (see Fig. 3A). These data are in agreement with results of earlier studies on lytic activity of PFO derivatives, which suggested that F318 and Y181 single mutations increase the activation energy for the monomer to pore transition explaining partial restoration of the lytic activity at 37 °C of PFOF318A and PFOY181A [19,23, 31,45]. In our hands, the toxin concentration yielding 50 % hemolysis (HA50) at 37 °C reached about 200 nM for PFOF318A, 1000 nM for PFOY181A in comparison to about 65 nM for PFO (Fig. 3B). The PFOF318A/Y181A double mutant showed no hemolytic activity, regardless of the incubation temperature (Fig. 3B). 
3.2. The effects of the F318A and Y181A mutations on the structure of PFO in solution
Our previous HDX-MS studies revealed an intertwined pattern of protected (structured) and unprotected (unstructured) regions along the PFO sequence [29]. The fraction of amide protons that were deuterated in all of the peptides that were common to all four protein variants after the proteins were incubated in deuterated solvent at 25 °C is shown in Fig. 4, either for 10 s incubation (Fig. 4A) or for 20 minutes of incubation (Fig. 4B). There were clear differences between the exchange rate in PFO versus PFOF318A, PFOY181A, and PFOF318A/Y181A (see also Supplementary Fig. 2A,B). The single site mutations at amino acid positions 181 and 318 increased the overall deuteration percentage at both times of incubation. This conclusion is exemplified by the exchange kinetics in the peptides from each of the PFO domains (Supplementary Fig. 3, Supplementary Tables 1,3,5,7), and in particular in the selected peptides, shown in Fig. 5. As can be seen for peptides of domains: D1 (pos. 123–132, peptide ii), D2 (pos. 76–92, peptide i), D3 (pos. 212–225, peptide iv), and D4 (pos. 422–439, peptide vii) (Fig. 4A,B; Fig. 5A,B,D,G), the single point mutations destabilized the secondary structure of all of the domains, with important local exceptions that are discussed below. 
	The destabilization due to a single point mutation was in majority of peptides stronger for PFOY181A than for PFOF318A (Fig. 4A,B; Supplementary Fig. 2A,B, Supplementary Fig. 3). Unexpectedly, the pattern of exchange in the double mutant was much closer to the pattern for PFO than to that of either of the single site mutants (Fig. 4A,B; Supplementary Fig. 2A,B; Supplementary Fig. 3). In many PFO regions, the F318A/Y181A double mutation fully compensated for the destabilization caused by the single site mutations, and in other regions, the compensation was partial, as in TMH1-β2 (pos. 212-225, peptide iv in Fig. 4A,B; Fig. 5D), β3-TMH2 (pos. 279-294) and β4-β5 (pos. 321-340, peptide v in Fig. 5E) in D3, as well as in the L2 (pos. 402-406, peptide vi) and L3 (pos. 422-439, peptide vii) loops in D4 domain (Fig. 5F,G). The effects of the mutations were not additive in any of the regions, and in all of the regions the H-bonding network stability was higher in the double mutant than in at least one of the single mutants. 
Surprisingly, it is in the D4 domain that is coupled to the rest of the molecule only by the S17 β-strand, where the observed destabilization effects of single mutations were the strongest. This was exemplified in two regions, the L2 C-terminus (pos. 402-406, peptide vi) and the UDP C-terminus (pos. 467-473, peptide viii), and the destabilization effect was partly retained in the double mutant (Fig. 4A,B; Fig.5 F,H).
	Interestingly, even though the single mutants showed general structural destabilization, we also detected some stabilized regions. For the PFOY181A, the strongest stabilization was observed for a region that encompassed the mutation site at which tyrosine 181 was substituted for alanine (pos.173–186, peptide iii in Fig. 4A,B, Fig. 5C), corresponding to the β1 strand. The effect was very strong: in the Y181A mutant, the peptide showed minimal exchange, even after 60 min of incubation with D2O, while in PFO 62 % of its amides were exchanged after 20 minutes. This stabilization was maintained when the second mutation, F318A, was added to produce the PFOF318A/Y181A double mutant (Fig. 4A,B; Fig. 5C). This was in stark contrast with the results for the rest of the protein (Fig. 4A,B). The presence of Y181 moiety introduces a structural strain in the β1 strand region, decreasing the thermodynamic barrier for β1 structural conversion during the transition to pore. 
Fig 6 shows the overview of the stabilization and destabilization pattern of the single and double mutants of PFO. It illustrates the overall destabilization caused by Y181A and F318A mutations and its reversion by double mutation F318A/Y181A. The strongest destabilization of the D4 domain in both of single and double mutants and stabilization induced by Y181A in β1 of the D3 domain are also evident. 
3.3.	The effect of mutations of other hydrophobic amino acids of the D3 domain on PFO structure and lytic activity
	The destabilization effect of single-site mutations was seen throughout the entire protein structure, indicating the widespread allosteric consequences of these mutations and thus strong structural coupling across the entire protein. The strong destabilization of PFO structure caused by single F318A or Y181A mutation and reverted by a double mutation indicates the strong cooperative stabilizing effect of both moieties in soluble form. This stabilizing effect cannot be explained by direct interaction between F318 and Y181 in the monomer (1PFO) because the distance between these two side chains is too far (~13 Å). In an agreement, the compensation effect of a double mutation in PFOF318A/Y181A also indicates that other interactions than the direct one between F318 and Y181 play a crucial role in the proper organization of the protein structure in their vicinity. The fact that both Y181 and F318 reside in a highly hydrophobic groove of the D3 domain (Supplementary Fig. 4) prompted us to check whether removing other hydrophobic amino acids from the groove will affect PFO stability in solution. Analysis of hydrogen-deuterium exchange after 20 min deuteration of PFO single-site mutants: L224A, L281A, I298A, and F338A showed that exchange rates within individual structural elements for these mutants were close to the exchange observed for PFO (selected regions shown in Fig. 7A; see also Supplementary Table 9). Differences in the level of deuteration in D1 and D3 domains did not exceed 10%. The exception was β1 which showed more significant destabilization in all mutants compared to PFO (the difference in deuteration level approached 20%). Surprisingly, the peptide encompassing UDP motif (pos. 467-473) was the only region in the PFO molecule that showed substantial destabilization in all PFO derivatives, and this effect was most pronounced in PFOL224A, PFOF281A, and PFOF338A. Neither of these mutations caused stabilization in 1 strand, as observed for Y181A.These results indicate that mutations of single hydrophobic amino acids (other than F318A or Y181A) did not affect substantially the general protein stability (with the exception of the UDP region) pointing to the crucial role of F318 and Y181 in maintaining the correct structural dynamics of PFO. Furthermore, substitution of F318 for tyrosine or Y181 for phenylalanine (F318Y and Y181F variants) did not exert such strong destabilizing effect as their substitution for less hydrophobic alanine. The exchange rates for F318Y and Y181F were similar to all the other PFO mutants considered in this set of experiments, while Y181F exerted the strongest destabilization of UDP (Fig. 7A). These data support a unique role of Y181 and F318 aromatic residues played in fine-tuning of protein stability. 
Hemolytic assay confirmed that slight changes in protein stabilization, observed in this series of discussed mutations did not affect substantially their lytic activity (HA50 reached value 20-70 nM for all proteins) (Fig. 7B) with L281A being even more efficient than PFO. This indicates that the replacement of hydrophobic residues filling the space between the rings of Y181 and F318 does not disturb the completeness of the hydrophobic groove, and suggests that F318 and Y181 are most important for driving structural transitions required for lytic activity.

3.4. The effects of the F318A and Y181A mutations on PFO structure upon binding to liposomes
Similar to what was observed in aqueous solution, upon interacting with liposomes, many regions of PFO were destabilized by the F318A and Y181A mutations (Fig. 4C,D; Fig. 6; Supplementary Fig. 2C,D; Supplementary Fig. 5; Supplementary Tables 2,4,6,8). Unlike what was observed in solution, the destabilization effect was more pronounced for PFOF318A than for PFOY181A in the presence of liposomes. The deuteration pattern was largely maintained for samples of liposome-bound proteins prepared by incubating PFO or its mutant derivatives with liposomes at 37 °C (Supplementary Fig. 6, Supplementary Table 10).
However, there were also specific regions that showed stabilization in the single mutants, especially in PFOY181A, and these became the most stable regions in the double mutant (Fig. 4C,D; Fig. 6). The stabilization was observed mainly in regions in the D1 domain (pos. 133-142, peptide i’ in Fig. 8A), but it was also seen for peptides in the loop linking β4 and β5 and in the β5 strand (pos. 321-340, peptide iv’ in Fig. 8D), and in the linker to α1 helix of D3 (pos. 351-362, peptide v’) (Fig. 8E). Localization of stabilized regions of PFO mutants overlaid on the toxin’s structure is shown in Fig. 9A. Interestingly, the extraordinary stability of β1 in both the single (Y181A) and double (F318A/Y181A) mutants in aqueous solution was retained in the presence of liposomes, while the PFOF318A gained the β1 stability comparable to that of liposome-bound PFO (Fig. 4C,D; Fig. 6). On the other hand, the regions following β1 in D3 and covering TMH1(pos. 201–207, peptide ii’) and β2 (pos. 212–225, peptide iii’) were strongly destabilized in PFOF318A in comparison to liposome-bound form of PFO (Fig. 6; Fig. 8B,C). In comparison to PFOF318A these regions were only slightly destabilized in PFOY181A and in the PFOF318A/Y181A. The strongest destabilization caused by the F318A mutation was for amino acid positions 180–300 and included the C-terminal part of the α1-helix in TMH2 (pos. 340–354), and β3 strand (pos. 279-294), but the coverage is not full in this region (Fig. 4C,D; Fig. 6; Fig. 9B). 
	Taken together, the HDX-MS results show a very complex pattern of changes in the stabilities of different regions of PFO, caused by point mutations, mostly F318A and Y181A, both in solution and in the presence of liposomes. These results suggest that the two single site mutations affect multiple elements that may be important for PFO structural transitions upon binding to cholesterol containing membranes. HDX-MS allowed to pinpoint elements that seem to be crucial in terms of the inability of the mutated variants to covert from solution form to pores, namely the over-stabilization of the β1 region in the solution structure caused by the removal of Y181 moiety, as well as stabilization the D1 domain, and C-terminus of the D3 domain including the β5 in the liposome-bound forms of PFO lacking Y181 and/or F318. 

4.	Discussion
	Formation of lytic pores by PFO is a complex process that involves several steps, including: binding to cholesterol-containing membrane, oligomerization (prepore formation) driven by interactions of β-strands in D3 domain of adjacent monomers, and incorporation into the lipid bilayer leading to the assembly of transmembrane pores [24,26]. Proper alignment of β strands is dictated by π-stacking interactions between aromatic residues located in β1 (Y181) and β4 (F318) of neighboring monomers [30]. This interaction forces a further structural transition within the D3 domain that relies on the formation of transmembrane β-hairpins, leading to the conversion of a prepore complex into a β-barrel pore. It is also thought to stabilize the prepore complex on the membrane surface, and maintain the correct angle of the PFO oligomer relative to the plane of the membrane [12,30,46].
	The results presented in this study revealed complex impact of F318 and Y181 on PFO structure and their distinct roles, which extend beyond their direct intermolecular interaction during PFO oligomerization. First, both single site mutations disrupted the stability of the entire protein structure, mainly its monomers in solution; thus, their influence is not only local - both residues seemed to be crucial for maintaining the proper stability of different protein regions. 
	Second, the destabilizing effects of each of the individual mutations were significantly compensated in the double mutant. This indicates that removal of one hydrophobic moiety, either Y181 or F318, leaves the second one exposed, leading to thermodynamically unfavorable molecular configurations and less stable structures. Third, and probably most importantly, our results show that the presence of the Y181 side chain natively destabilizes the H-bonding network in the β1 strand region in PFO, while presence of Y181 and F318 destabilizes strand 5 in the presence of lipids. This identifies an important new molecular mechanism that may be responsible for the ability to form intermolecular β1-β4 pairing. In the absence of the Y181 side chain (in PFOY181A), the β1 strand becomes exceptionally stable, even in solution. This indicates that the tyrosine ring in the native context of PFO monomer is engaged in the network of interactions that significantly destabilize β1. Removal of F318 moiety in the presence of Y181 (F318A) destabilized 1, while in the absence of Y181 lack of F318 had no effect, as 1 stability is the same in PFOF318A/Y181A and PFOY181A (Fig. 10A). On the other hand F318A leads to overall destabilization in the presence of lipids, accompanied by stabilization of 5 region. Thus, F318, acting cooperatively with Y181, helps in fine-tuning of the stability of the system of  strands at the level enabling efficient alignment of β-strands from adjacent monomers. Non-native stability of β1, 5 strands, observed in PFO bearing Y181A, F318A mutations may itself impair or contribute to the impairment of oligomerization, and in result decrease their lytic activity.
	The effects of the single and double mutations on the whole protein structure can be analyzed in terms of the double-mutant thermodynamic cycle, which applies when a free energy associated with a structural property of a protein bearing two mutations is not the sum of energy changes induced by two single mutations [45]. Our analysis revealed the destabilizing influences of each single F318A or Y181A mutation which was compensated in double F318A/Y181A mutant (Fig. 10B). This indicates non-additivity of the effects of the two single mutations and the presence of strong cooperative stabilizing effect when both F318 and Y181 side chains were in place. The cooperative effect compensated for the destabilizing influences of each single mutation, which is in agreement with the absence of a strong intramolecular interaction between F318 and Y181. Strong mutual interaction would cause significant destabilization in both single mutants, not followed by any change in stability for a double mutant, which is not the case. Instead, we observed the nearly full compensation of single mutation destabilization and return to PFO stability in the double mutant. This unusual effect can be understood as follows: in the single mutants, remaining residue (either F318 or Y181) lacks its “partner” and engages in the network of interactions in a way that decreases the stability of all of the protein domains. Thus, the decrease in stability observed in the single mutants is not due to a lack of interactions caused by the mutated residue; instead, it is caused by the generation of non-native interactions by the remaining side chain (F318 in PFOY181A and Y181 in PFOF318A) with other amino acid residues located in the same highly hydrophobic groove. The completeness of this hydrophobic groove is strongly distorted by the F318A or Y181A mutations. In thermodynamic terms, there is a substantial unfavorable hydrophobic effect of the lack of F318 or Y181, and the surfaces exposed due to removal of either of these hydrophobic amino acid need to be shielded by structural rearrangements, even at the cost of destabilization of the protein structure. Such rearrangements were significant for the single mutants (PFOY181A and PFOF318A), being only mild for the double mutant (PFOF318A/Y181A). This indicates that the network of interactions, involving F318 and Y181 may be important for fine-tuning protein stability and for driving structural transitions during pore formation. Mutation of any other hydrophobic amino acids (L224, L281, I298, F338) filling the space between the rings of F318 and Y181 did not affect the PFO structural stability in solution and its lytic activity. Substitution of these residues is accommodated without major perturbation of the structure, indicating that the function of these hydrophobic amino acid residues (other than F318 and Y181) can be redundant if Y181 and F318 are present in place. On the other hand, stability of 1 strand in variants lacking these residues is lower than in PFO, so their absence enhances the destabilizing role of Y, in case of L281A correlating with increased lytic activity.
	We found that, upon binding to liposomes, single (F318A and Y181A) and double (F318A/Y181A) mutations resulted in stabilization of various regions of PFO (β1 and β5) which engaged in oligomerization (Fig. 6; Fig. 9A). Rotation of the β5 strand away from β4 exposes β4 to the polar environment, leading to its association with β1 on the neighboring PFO monomer. Our studies indicate that increased stability of β5 may affect the structural transitions in the D3 domain that are essential for the transformation of the helical TMHs to β-hairpins. This stabilization could shield β4 from intermolecular interactions, potentially decreasing the efficiency of the pore formation and explain the partial decrease of lytic activity, which is marked in the single-site mutants and prominent in the double mutant. The change in the stability of β5 is accompanied by parallel structural stabilization in D1 (Fig. 9A), which was only seen in liposomes and which is the result of oligomerization. It was previously shown that D1 is also an active player in pore-forming structural transformations [29]. We find it likely that D1 over-stabilization may be coupled to stabilization of the β5 region and thus may mechanistically prevent formation of lytic pores. 
	In conclusion, our results revealed a complex network involving crucial residues that drive structural transition in PFO necessary for its lytic activity. One novel finding was that elements of this network serve to fine-tune β1 strand stability, which may be crucial for efficient structural transitions from monomers to oligomers. Another novel finding was the over-stabilization of the β5 strand and the D1 domain in mutants make the transition from pre-pores to pores less probable. We also found that direct interactions of Y181 and F318 may not be the only factor contributing to their role in monomer to pore transition, since we observe also their impact on the stability of D3 strands that are functionally important; rather, these local interactions are accompanied by the involvement of these residues in allosteric regulation of the entire protein-stabilizing network. These global effects must be taken into account when interpreting the results of studies that involve the mutation of critical residues. 
Abbreviations: DOPC, 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine; HDX-MS, hydrogen deuterium exchange mass spectrometry; LUVs, large unilamellar vesicles; PFO, cysteine-less perfringolysin O; RBC- red blood cell; RU, relative units; SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis; SDS-AGE, sodium dodecyl sulfate agarose gel electrophoresis; SPR- surface plasmon resonance; SM, N-(hexadecanoyl)-sphing-4-enine-1-phosphocholine; SPR, surface plasmon resonance; SUVs, small unilamellar vesicles.
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Figure legends
Fig. 1. The crystal structure of the monomeric form of PFO and the structural transition of PFO upon its interaction with cholesterol-containing membrane. (A) The crystallographic structure of the water-soluble monomer of PFO (PDB ID: PFO1) as obtained by Rossjohn [6] showing the domains. The secondary structural elements are as follows: β- sheets are red, α-helices are blue, and the remaining structures (including loops) are yellow. The structures and amino acid residues that are crucial for our experiments are indicated and shown on the magnified view of the D3 domain. (B) Binding of the PFO monomer to the membrane forces β5 to rotate away from β4, exposing β4 to the polar environment and allowing the formation of hydrogen bonds with β1 from another PFO monomer. 
Fig. 2. SPR analysis of the binding PFO to cholesterol-containing liposomes. SPR sensorgrams of PFO (──), PFOF318A (─ ─), PFOY181A (─●─), and PFOF318A/Y181A (●●●) binding to liposomes composed of DOPC/cholesterol (A) and DOPC/SM (B) that were immobilized on the surface of an L1 sensor chip. Sensorgrams were performed in triplicate, and one representative experiment is shown.
Fig. 3. The effect of the F318A and Y181A mutations on PFO oligomer formation and hemolytic activity. (A) The formation of SDS-resistant oligomers upon the binding of PFO and its mutant derivatives to liposomes composed of DOPC/cholesterol. Small unilamellar liposomes composed of DOPC/cholesterol (2 mM total phospholipids) were incubated with 1 µM PFO, PFOF318A, PFOY181A or PFOF318A/Y181A for 45 min at 25 °C or 37 °C. Pelleted liposomes were subjected to 1.5% SDS-AGE and analyzed for the presence of monomers and oligomers of PFO. (B) Hemolytic activity of PFO (──), PFOF318A (─ ─), PFOY181A (─●─) and PFOF318A/Y181A (●●●). RBCs were incubated with the recombinant proteins at the indicated concentrations for 45 min at 25 °C (left panel) and 37 °C (right panel). The amount of released hemoglobin was evaluated spectrophotometrically and expressed as a percentage of the total amount of hemoglobin released by osmotic lysis of RBCs. The results are the means ± SDs of three experiments.
Fig. 4. The hydrogen-deuterium exchange patterns for PFO and PFO derivatives: PFOF318A, PFOY181A, and PFOF318A/Y181A in aqueous solution and after incorporation into liposomes at 25 °C. Plots show the hydrogen-deuterium exchange pattern of amide protons (y axis) for PFO (black), PFOF318A (yellow), PFOY181A (blue), and PFOF318A/Y181A (red) in aqueous solution (A, B) and incorporated into liposomes (C, D) after 10 s (A, C) and after 20 min (B, D) of exchange. The position of the peptides in the protein sequence and their lengths are shown on the x axis. Regions that form protein domains (D1–D4), beta strands (β), transmembrane helices (TMH), and C-terminal loops (L1–L3 and UDP) are indicated at the top of the graph. The y-axis error bars show standard deviations that were calculated from at least three independent experiments. Peptides in squares with dashed lines and labelled i–viii (A and B) and i’–v’ (C and D) indicate peptides shown in Fig. 5 and Fig 8, respectively. 
Fig. 5. Kinetics of hydrogen-deuterium exchange in selected PFO and PFO derivatives: PFOF318A, PFOY181A, and PFOF318A/Y181A peptides in aqueous solution. Deuteration was measured after exposure of the proteins to D2O for 10 s, 5 min, 20 min, and 60 min. Deuterium uptake is shown on linear and logarithmic timescales for peptides marked by i-viii in Fig. 4A,B. The peptides are at positions: (A) 76–92 (IVVERQKRSLTTSPVD), (B) 123–132 (MVKRKPININ), (C) 173–186 (HTLPARTQYSESMV), (D) 212–225 (NAVANNEKKVMILA), (E) 321–340 (VVLGGDAQEHNKVVTKDFDE), (F) 402–406 (YVAQF), (G) 422–439 (VLTHKTWDGNYQDKTAHY), (H) 467–473 (WRDVISE) for PFO (black), PFOF318A (yellow), PFOY181A (blue), and PFOF318A/Y181A (red). Error bars show standard deviations that were calculated from at least three experiments. 
Fig. 6. The degree of stabilization or destabilization of structural elements in individual PFO derivatives: PFOF318A, PFOY181A, and PFOF318A/Y181A compared to PFO. Data are prepared by subtraction of the fraction of hydrogen-deuterium exchange of PFO from PFO mutants after 20 min of exchange in aqueous solution (AQ) and upon binding to liposomes (LIPO). Single peptides representing a specific structural element of PFO were taken for analysis and its position in PFO sequence is indicated. Value of the difference in exchange level for each region is color coded. Red, orange and yellow regions (positive values) indicate structural elements that are destabilized in PFO mutants; cyan, blue, and dark blue regions (negative values) represent structural elements that are more stable in PFO mutants than in PFO; white regions correspond to unchanged regions. 
Fig. 7. The effect of the single site mutations: Y181F, L224A, L281A, I298A, F318Y, F338A on the hydrogen-deuterium exchange level in selected peptides of PFO and hemolytic activity. (A) Plot shows the hydrogen-deuterium exchange level of amide protons (y axis) for PFO (black), PFOF318Y (violet), PFOY181F (green), PFOI298A (blue), PFOF338A (red), PFOL224A (orange), and PFOL281A (magenta) in aqueous solution after 20 min of exchange. Selected and common for all mutant derivatives peptides are presented: MVKRKPININ (pos. 123-132); HTLPARTQYSESMV (173-186); NAVANNEKKVMILA (212-225); VKLETTSSSKDVQAAF (279-294); IRKVIKDNATF (341-351); FSTKNPAYPISY (351-362); YVAQF (402-406); WRDVISE (467-473). The y-axis error bars show standard deviations that were calculated from at least three independent experiments. (B) Hemolytic activity of PFO and its mutant derivatives. Sheep red blood cells (RBCs) were incubated with the recombinant proteins at the indicated concentrations for 45 min at 37 °C. The amount of released hemoglobin was evaluated spectrophotometrically and expressed as a percentage of the total amount of hemoglobin released by osmotic lysis of RBCs. The color coding is the same as in A.
Fig. 8. Kinetics of hydrogen-deuterium exchange in selected PFO and PFO derivatives: PFOF318A, PFOY181A, and PFOF318A/Y181A peptides upon incorporation into liposomes. Deuteration was measured after incubation of liposome-bound proteins in D2O for 10 s, 5 min, 20 min, and 60 min. Deuterium uptake is shown on linear and logarithmic timescales for peptides marked by i-v in Fig. 4A,B. The peptides are at positions: at position (A) 133–142 (IDLPGLKGEN), (B) 201–207 (KVLENSL), (C) 212–225 (NAVANNEKKVMILA), (D) 321–340 (VVLGGDAQEHNKVVTKDFDE), and (E) 351–362 (FSTKNPAYPISY) for PFO (black), PFOF318A (yellow), PFOY181A (blue), and PFOF318A/Y181A (red). Error bars show standard deviations that were calculated from least three experiments.
Fig. 9. Schematic representation showing the HDX-MS results overlaid on the structure of PFO. The HDX-MS results for 20 min of deuterium exchange reaction of liposome-bound PFO, PFOF318A, PFOY181A and PFOF318A/Y181A are shown. Blue indicates the peptides that are more stable in PFOF318A, PFOY181A, and PFOF318A/Y181A than in PFO (A). Red indicates the peptides that are more destabilized in PFOF318A than in PFO (B). 
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